In the present work, we demonstrated that the direct inhibition of thrombin activity by dabigatran effectively prevented the development of Ang II-induced endothelial dysfunction and endothelial inflammation, however without affecting elevated blood pressure and vascular remodelling. Here, AGT is linked to endothelial dysfunction.